Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
株式のランク #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$2.62K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Anthera Pharmaceuticals, Inc. (ANTH)

カテゴリー

Anthera Pharmaceuticals, Inc.(ANTH)の配当利回りの履歴
Anthera Pharmaceuticals, Inc.(銘柄コード: ANTH)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Anthera Pharmaceuticals, Inc.(ANTH)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)